Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUTAmate for Metabolic Intervention in Coronary Surgery II
2011-006241-15Phase 3Completed
- Sponsor
- University Hospital, Linköping
- Start
- Dec 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Glutamic acid in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by University Hospital, Linköping. Primary endpoints: Primary composite endpoint, Cardiac mortality and 2 more. Started Dec 2011; status: completed.
02
Drugs
Glutamic acid
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on 2011-006241-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006241-15.